Triamcinolone acetonide facilitates removal of the epiretinal membrane and separation of the residual vitreous cortex in highly myopic eyes with retinal detachment due to a macular hole

Ophthalmologica

Volumn 218, Issue 4, 2004, Pages 248-256

  Yamamoto, Narumichi ^a   Ozaki, Noriko ^a   Murakami, Kimio ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Epiretinal membrane; Macular hole; Pars plana vitrectomy; Residual vitreous cortex; Retinal detachment; Triamcinolone acetonide

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CILIARY DISK; CLINICAL ARTICLE; EPIRETINAL MEMBRANE; FEMALE; HIGH MYOPIA; HUMAN; MALE; RETINA DETACHMENT; RETINA MACULA HOLE; SIDE EFFECT; SURGICAL TECHNIQUE; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT OUTCOME; VITRECTOMY; VITREOUS BODY;

AGED; EPIRETINAL MEMBRANE; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MALE; MIDDLE AGED; MYOPIA; RETINAL DETACHMENT; RETINAL PERFORATIONS; TRIAMCINOLONE ACETONIDE; VITRECTOMY; VITREOUS BODY; VITREOUS DETACHMENT;

EID: 3242752119     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078615     Document Type: Article

References (23)

1. Stirpe M, Michels RG: Retinal detachment in highly myopic eyes due to macular holes and epiretinal traction. Retina 1990;10:113-114.
2. Seike C, Kusaka S, Sakagami K, Ohashi Y: Reopening of macular holes in highly myopic eyes with retinal detachments. Retina 1997;17:2-6.
3. Oshima Y, Ikuno Y, Motokura M, Nakae K, Tano Y: Complete epiretinal membrane separation in highly myopic eyes with retinal detachment resulting from a macular hole. Am J Ophthalmol 1998;126:669-676.
4. Kusaka S, Hayashi N, Ohji M, Hayashi A, Kamei M, Tano Y: Indocyanine green facilitates removal of epiretinal and internal limiting membranes in myopic eyes with retinal detachment. Am J Ophthalmol 2001;131:388-390.
5. De Juan E Jr, Hickingbotham D, McCuen BW 2nd, Machemer R: The pic-forceps for removal of epiretinal membranes. Am J Ophthalmol 1984;98:518-519.
6. Gandorfer A, Messmer EM, Ulbig MW, Kampik A: Indocyanine green selectively stains the internal limiting membrane. Am J Ophthalmol 2001;131:387-388.
7. Tu EY, Culbertson WW, Pflugfelder SC, Huang A, Chodosh JC: Therapy of nonnecrotizing anterior scleritis with subconjunctival corticosteroid injection. Ophthalmology 1995;102:718-724.
8. Hakin KN, Ham J, Lightman SL: Use of orbital floor steroids in the management of patients with uniocular non-necrotising scleritis. Br J Ophthalmol 1991;75:337-339.
9. Gould ES, Bird AC, Leaver PK, McDonald WI: Treatment of optic neuritis by retrobulbar injection of triamcinolone. BMJ 1977;1:1495-1497.
10. Peyman GA, Cheema R, Conway MD, Fang T: Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 2000;20:554-555.
11. Sakamoto T, Miyazaki M, Hisatomi T, Nakamura T, Ueno A, Itaya K, Ishibashi T: Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol 2002;240:423-429.
12. Lewis JM, Park I, Ohji M, Saito Y, Tano Y: Diamond-dusted silicone cannula for epiretinal membrane separation during vitreous surgery. Am J Ophthalmol 1997;124:552-554.
13. Schwartz SD, Alexander R, Hiscott P, Gregor ZJ: Recognition of vitreoschisis in proliferative diabetic retinopathy: A useful landmark in vitrectomy for diabetic traction retinal detachment. Ophthalmology 1996;103:323-328.
14. Gandorfer A, Messmer EM, Ulbig MW, Kampik A: Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 2000;20:126-133.
15. Kampik A, Green WR, Michels RG, Nase PK: Ultrastructural features of progressive idiopathic epiretinal membrane removed by vitreous surgery. Am J Ophthalmol 1980;90:797-809.
16. Kampik A, Kenyon KR, Michels RG, Green WR, Cruz ZC de la: Epiretinal and vitreous membranes: Comparative study of 56 cases. Arch Ophthalmol 1981;99:1445-1454.
17. Messmer EM, Heidenkummer HP, Kampik A: Ultrastructure of epiretinal membranes associated with macular holes. Graefes Arch Clin Exp Ophthalmol 1998;236:248-254.
18. Park DW, Dugel PU, Garda J, Sipperley JO, Thach A, Sneed SR, Blaisdell J: Macular pucker removal with and without internal limiting membrane peeling: Pilot study. Ophthalmology 2003;110:62-64.
19. Kadonosono K, Yazama F, Itoh N, Uchio E, Nakamura S, Akura J, Sawada H, Ohno S: Treatment of retinal detachment from macular hole with internal limiting membrane removal. Am J Ophthalmol 2001;131:203-207.
20. Ikuno Y, Sayanagi K, Oshima T, Gomi F, Kusaka S, Kamei M, Ohji M, Fujikado T, Tono Y: Optical coherence tomographic findings of macular holes and retinal detachment after vitrectomy in highly myopic eyes. Am J Ophthalmol 2003;136:477-481.
21. Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, ffytche TJ, Marshall J: Intravitreal triamcinolone for uveitic cystoid macular edema: An optical coherence tomography study. Ophthalmology 2001;108:765-772.
22. McCuen BW 2nd, Bessler M, Tano Y, Chandler D, Machemer R: The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol 1981;91:785-788.
23. Hida T, Chandler D, Arena JE, Machemer R: Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol 1986;101:190-195.